In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...

Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...

A dietetics professor explains who should and should not embrace the latest weight-loss drugs. Holiday weight gain hits home ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Ozempic is available in India but may not be as widely accessible as in other countries. Keep reading as we answer some FAQs ...